Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/23/2013
New Reports Predict Rising Consumption of Diabetes Drugs and Insulin i...
12/21/2013
BMS Sells Global Diabetes Business to AstraZeneca Pending Antitrust an...
11/29/2013
New Report: Chinese Diabetes Drug Market to See Substantial Growth thr...
11/20/2013
Diabetes Prevalence Rises Faster in Rural Areas
11/20/2013
India to Launch New Measure to Restrict Foreign Investment in Pharma I...
11/18/2013
Eli Lilly Invests US$350M to Expand Its Insulin Cartridge Production C...
10/24/2013
Salubris Pharma Licenses China Rights of Fotagliptin from Fosun
10/22/2013
Chinese Smuggling of Low Cost Indian Cancer Medicines Gains Momentum
10/21/2013
Fosun Subsidiary Outlicenses Two Diabetes Drug Candidates to Sellas
9/17/2013
Escalating Diabetes Prevalence Threatens to Bankrupt China
9/4/2013
China Warned of A Major Epidemic of Diabetes-related Complications
8/8/2013
China's Type II Diabetes Drug Market to Grow 10% CAGR by 2017
8/7/2013
ScinoPharm Forms Strategic Alliance with Sundia MediTech for CRAMS
8/6/2013
India Partially Revokes Patent of Roche's Herceptin
7/31/2013
Takeda Gets CFDA Approval for Import of Diabetes Drug Nesina
7/2/2013
China Maintains Antidumping Duties on SMZ from India
6/17/2013
Chinese Diabetes Drug Market to Maintain Double-digit Growth by 2017
4/24/2013
Takeda Lines Up with Sanofi to Co-promote Its Diabetes Drug Alogliptin
4/21/2013
Bayer's Star Contraceptive Diane-35 under EMA Investigation
4/12/2013
AZ and BMS to Co-market BYETTA in China
4/2/2013
Novartis Loses Landmark Patent Case for Glivec
3/19/2013
BMS to Launch At Least Four More Diabetes Drugs in China by 2015
3/19/2013
Merck KGaA, BMS Join Hands for Co-promotion of Glucophage in China
3/1/2013
Ipsos: Most Type 2 Diabetes Patients in China Yet to Benefit from Newe...
2/1/2013
Pharmaceutical Company Loses CNY 1 Billion after 140-word Weibo Messag...
1/30/2013
Merck Launches Janumet in China
1/25/2013
New Report: Chinese Diabetes Drug Market Dominated by Insulin Products
12/26/2012
Are East Asians More at Risk for Type-2 Diabetes?
12/19/2012
India Imports Most APIs from China
11/30/2012
Government Seeks to Boost Pediatric Drugs with More Incentive Policies
Page:
10
/
16
Total number of articles:
474
:
[First]
[<<]
[8]
[9]
[10]
[11]
[12]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit